financetom
Business
financetom
/
Business
/
HeartCore Enterprises Shares Rise After Q3 Revenue, Profit Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
HeartCore Enterprises Shares Rise After Q3 Revenue, Profit Guidance
Oct 3, 2024 1:28 AM

12:29 PM EDT, 09/25/2024 (MT Newswires) -- HeartCore Enterprises ( HTCR ) shares rose 7.5% in recent trading Wednesday after the company posted Q3 revenue guidance of $19 million to $23 million.

A lone analyst polled by Capital IQ expected $20.1 million.

HearCore said Wednesday it generated $17.9 million in revenue from a deal with SBC Medical Group, and $17 million will be recognized in Q3.

The company said it expects Q3 net profit of $4 million to $8 million.

Price: 0.83, Change: +0.06, Percent Change: +7.52

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lake Shore Bancorp Unit Gets Termination Notice for Federal Regulator's Consent Order
Lake Shore Bancorp Unit Gets Termination Notice for Federal Regulator's Consent Order
Dec 3, 2024
06:07 PM EST, 12/03/2024 (MT Newswires) -- Lake Shore Bancorp ( LSBK ) said late Tuesday that the Office of the Comptroller of the Currency terminated a consent order that required its Lake Shore Savings Bank unit to address deficiencies in areas such as information technology, security, audit, and management. The federal regulator also terminated the troubled condition status, the...
ETFs tracking securitized debt, AI and Novo Nordisk add to industry's banner 2024
ETFs tracking securitized debt, AI and Novo Nordisk add to industry's banner 2024
Dec 3, 2024
(Reuters) - Three separate asset management firms launched exchange-traded funds on Tuesday, unveiling products focused on securitized debt, the artificial intelligence industry and Ozempic-maker Novo Nordisk in the closing weeks of a year that has seen a deluge of new funds. New ETF offerings have exploded in 2024, as investors sought ways to participate in the soaring U.S. stock market....
Heron Therapeutics Shares Surge on Favorable Cinvanti Patent Ruling
Heron Therapeutics Shares Surge on Favorable Cinvanti Patent Ruling
Dec 3, 2024
06:07 PM EST, 12/03/2024 (MT Newswires) -- Heron Therapeutics ( HRTX ) shares surged 91% in after-hours trading Tuesday after the company said it won a patent dispute over its Cinvanti injectable emulsion against Fresenius Kabi USA. The US District Court for the District of Delaware ruled that Heron's US patents, which expire in 2035, are valid and would be...
ETFs tracking securitized debt, AI and Novo Nordisk add to industry's banner 2024
ETFs tracking securitized debt, AI and Novo Nordisk add to industry's banner 2024
Dec 3, 2024
Dec 3 (Reuters) - Three separate asset management firms launched exchange-traded funds on Tuesday, unveiling products focused on securitized debt, the artificial intelligence industry and Ozempic-maker Novo Nordisk in the closing weeks of a year that has seen a deluge of new funds. New ETF offerings have exploded in 2024, as investors sought ways to participate in the soaring U.S....
Copyright 2023-2026 - www.financetom.com All Rights Reserved